਀㰀栀琀洀氀㸀 ਀㰀氀椀渀欀 爀攀氀㴀∀猀琀礀氀攀猀栀攀攀琀∀ 琀礀瀀攀㴀∀琀攀砀琀⼀挀猀猀∀ 栀爀攀昀㴀∀猀琀礀氀攀⸀挀猀猀∀⼀㸀 ਀㰀戀漀搀礀㸀

Centre de Référence des Rhumatismes Inflammatoires et Maladies Autoimmunes Systémiques Rares de l’Enfant (RAISE) / 2017

55

Ruperto

N,

Martini

A.

Juvenile

idiopathic
malignancy.

arthritis

and

Rheumatology

(Oxford).

2014

Jun;53(6):968–

74.

AJI Polyarticulaire

Revues générales

Hinze

C,

Gohar

F,

Foell

D.

Management

of

idiopathic

juvenile

arthritis:

hitting

the

target.

Nat

Rev

Rheumatol.

2015 May;11(5):290–300.

Webb

K,

Wedderburn

LR.

Advances

in

the

treatment

of

polyarticular

juvenile

idiopathic

arthritis.

Curr

Opin

Rheumatol.

2015 Sep;27(5):505–10.

Critères de rémission

Consolaro

A,

Bracciolini

G,

Ruperto

N,

Pistorio

A,

Magni-

Manzoni

S,

Malattia

C,

et

al.

Remission,
activity,
symptom
idiopathic

minimal

disease

acceptable

and

state

in

arthritis:

juvenile

defining

criteria

based

on

the

juvenile

arthritis

disease

activity

score.

Arthritis

Rheum.

Jul;64(7):2366–74.

2012

Wallace

CA,

Giannini

EH,

Huang

B,

Itert

L,

Ruperto

N,

Childhood
Rheumatology

Arthritis

Research

Alliance, et al. American College

of

Rheumatology

provisional

criteria
inactive

for

defining

clinical

select

disease

in

categories

of

juvenile

idiopathic

arthritis.

Arthritis

Care

Res

(Hoboken).

2011

Jul;63(7):929–

36.

Méthotrexate

Brunner HI, Ruperto N, Zuber

Z,

Keane

C,

Harari

O,

Kenwright

A,

et

al.

Efficacy

and

safety

of

tocilizumab

in

patients

with

polyarticular-

course

juvenile

idiopathic

arthritis: results from a phase

3,

randomised,

double-blind

withdrawal

trial.

Ann

Rheum

Dis. 2015 Jun;74(6):1110–7.

Goëb

V,

Ardizzone

M,

Arnaud

L,

Avouac

J,

Baillet

A,

Belot

A,

et

al.

Recommendations

for

using

TNFα
French

antagonists

and

Practice

Clinical

Guidelines

endorsed

by

the

French

National

Authority

for

Health.

Joint

Bone

Spine.

2013 Dec;80(6):574–81.

Klein

A,

Kaul

I,

Foeldvari

I,

Ganser

G,

Urban

A,

Horneff

G. Efficacy and safety of oral
and

parenteral

methotrexate

therapy

in

children

with

juvenile idiopathic arthritis: an

observational

study

with

patients

from

the

German

Methotrexate

Registry.

Arthritis Care Res (Hoboken).
2012 Sep;64(9):1349–56.

Tynjälä

P,

Vähäsalo

P,

Honkanen

V,

Lahdenne

P.

Drug

survival

of

the first

and

second course of anti-tumour

necrosis
juvenile

factor

agents

in

idiopathic

arthritis.

Ann

Rheum

Dis.

Apr;68(4):552–7.

2009

Albers

HM,

Wessels

JAM,

van der Straaten RJHM, et al.

਀㰀⼀栀琀洀氀㸀